AAA June 2012 – Page 7

Basilea Pharmaceutica sells drug to GSK’s Stiefel

Basilea Pharmaceutica, a spin-off from Switzerland pharmaceutical company Roche, has sold eczema drug Toctino to Stiefel, part of GlaxoSmithKline for £146m ($228.4m) upfront payments and up to £50m in milestone payments. Basilea was founded in 2000 as a spin from Swiss pharmaceutical group Roche and it went public on the SIX Swiss Exchange in 2004.… Continue reading Basilea Pharmaceutica sells drug to GSK’s Stiefel

The Big Deal: Isentropric meets ETI

It is always interesting to see more organisations with corporate links getting involved in venture investing. Last week, the latest entrant to early stage investing was UK-based public-private partnership Energy Technologies Institute, which made its first equity investment in a private company by backing UK-based energy storage business Isentropic with £14m ($22m). The Energy Technologies… Continue reading The Big Deal: Isentropric meets ETI

Corporates hold their nerve

In a difficult month for global markets, with big slides and volatility in equity markets as concerns grow around the eurozone crisis, corporate venturing groups are confident. Global Corporate Venturing tracked 67 investments worth $1.39bn in May. This was down against the 83 worth $1.46bn in April and the 80 in May last year worth… Continue reading Corporates hold their nerve

Cisco identifies triple helix model for innovation

Anne Lange, director of the global public sector at Cisco’s internet business solutions group, says: “The knowledge-based economy puts a
stronger emphasis on the value of knowledge capital and access to primary sources of innovation. It forces academics, politicians and businesses to shape new collaborations and decrypt, together, these complex ecosystems.”

Symposium round-up

This article features some of the notable points and soundbites from the 39 keynotes and panel discussions at the Global Corporate Venturing Symposium 2012. For the transcripts and slides (where available) of the presentations, please click on the links.